Or Not. 20B shares and a lot of disgruntled shareh

Or Not. 20B shares and a lot of disgruntled shareholders. Need to completely restructure AND still looking for S African reclassification of medicinal mj. Long, long, long process. Last up-date was in March. Here is the latest:

BOCA RATON, FL--(NewMediaWire - Sep 20, 2017) - Protext Pharma, Inc. (PINKSHEETS: TXTM) ("Protext" or "the Company", a biotech company engaged in the development of pharmaceutical botanical medicines that are formulated with highly-bioavailable plant extracts, today announced that the government of South Africa published recommended amendments to the Medical Innovation Bill that would change the status of cannabis products that do not have psychoactive properties from a Schedule 7 prohibited substance to a Schedule 4 substance. Schedule 4 drugs, which include antibiotics and corticosteroids, may be given verbally to the pharmacist by the doctor, although such instruction must be followed up by a written prescription within 7 days. Under the proposed guidelines, Cannabis sold "on the street" will remain a Schedule 7 substance and be prohibited. Protext Pharma anticipates that its Phytofare® Cannabinoid extract will be non-psychoactive and thus fall under the Schedule 4 classification.

'Everything works out in the end,,,If it hasn't worked out,,it's not the end'


https://twitter.com/twitter/statuses/957208055766241280